RCE in Sourcecodester Drug Recommendation System
CVE-2026-94033
A vulnerability has been found in SourceCodester Drug Recommendation System 1.0. This vulnerability affects unknown code of the file /drug_recommender/Admin/add_user of the component User Management. Such manipulation of the argument txtname/txtemail/txtpassword leads to cross site scripting. It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used.
Vulnerability class: XSS (Cross-Site Scripting)
Published · last modified .
CVSS v3 metric
CVSS v3 base score 3.5 (Low). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N.
EPSS exploit prediction
EPSS: 0.003 (28.5th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 28th percentile — 28.5% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.003 · newest: 0.003 · change: 0.000
Affected products
- Sourcecodester Drug Recommendation System — versions 1.0
Weakness classification (CWE)
References
- VDB-407961 | SourceCodester Drug Recommendation System User Management add_user cross site scripting (technical-description, vdb-entry)
- VDB-407961 | CTI Indicators (IOB, IOC, TTP, IOA) (signature, permissions-required)
- CVE-2026-94033 | CVE Analysis and Report (third-party-advisory)
- Submit #946133 | SourceCodester Drug Recommendation System Using Machine Learning, PHP, and MySQL Database 1.0 Cross Site Scripting (third-party-advisory)
- github.com/KaranParelkar/Drug_recommendation_system/blob/main/xss/add_user/Read… (exploit)
- www.sourcecodester.com/ (product)
Frequently asked questions
- What is CVE-2026-94033?
- CVE-2026-94033 is a low-severity vulnerability in Sourcecodester Drug Recommendation System, classified under Cross-site Scripting. CVSS score: 3.5/10. Published 2026-09-20.
- How severe is CVE-2026-94033?
- Low severity. CVSS v3 base score is 3.5 out of 10.